Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S1473-3099(20)30461-8 http://scihub22266oqcxt.onion/10.1016/S1473-3099(20)30461-8 32717208!7380944!32717208     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet+Infect+Dis 2020 ; 20 (10): e268-e273 Nephropedia Template TP {{tp|p=32717208|t=2020. Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential |pdf=|usr=}}{{32717208}} gab.com Text Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential JO: Lancet Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32717208 #FOAvip Outbreaks of infectious diseases are occurring with increasing frequency and unpredictability. The rapid development and deployment of diagnostics that can accurately and quickly identify pathogens as part of epidemic preparedness is needed now for the COVID-19 pandemic. WHO has developed a global research and innovation forum to facilitate, accelerate, and deepen research collaboration among countries and funders. Great progress has been made in the past decade, but access to specimens remains a major barrier for the development and evaluation of needed quality diagnostics. We present a sustainable model for a global network of country-owned biobanks with standardised methods for collection, characterisation, and archiving of specimens and pathogens to facilitate and accelerate diagnostics development and evaluation for COVID-19 and other diseases of epidemic potential. The biobanking network should be run on the guiding principles of transparency, equitable access, ethics, and respect for national laws that support country ownership and sustainability. Adapting the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits, sharing of specimens from national biobanks can be rewarded through mechanisms such as equitable access to diagnostics at negotiated prices. Such networks should be prepared for any pathogen of epidemic potential. Twit Text FOAVip Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential ????Lancet Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32717208 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32717208 #FOAvip English Wikipedia <ref>{{Cite pmid|32717208}}</ref> Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential #MMPMID32717208 Peeling RW; Boeras D; Wilder-Smith A; Sall A; Nkengasong J Lancet Infect Dis 2020[Oct]; 20 (10): e268-e273 PMID32717208show ga Outbreaks of infectious diseases are occurring with increasing frequency and unpredictability. The rapid development and deployment of diagnostics that can accurately and quickly identify pathogens as part of epidemic preparedness is needed now for the COVID-19 pandemic. WHO has developed a global research and innovation forum to facilitate, accelerate, and deepen research collaboration among countries and funders. Great progress has been made in the past decade, but access to specimens remains a major barrier for the development and evaluation of needed quality diagnostics. We present a sustainable model for a global network of country-owned biobanks with standardised methods for collection, characterisation, and archiving of specimens and pathogens to facilitate and accelerate diagnostics development and evaluation for COVID-19 and other diseases of epidemic potential. The biobanking network should be run on the guiding principles of transparency, equitable access, ethics, and respect for national laws that support country ownership and sustainability. Adapting the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits, sharing of specimens from national biobanks can be rewarded through mechanisms such as equitable access to diagnostics at negotiated prices. Such networks should be prepared for any pathogen of epidemic potential. |Betacoronavirus/isolation & purification[MESH] |Biological Specimen Banks/*organization & administration/*standards[MESH] |COVID-19[MESH] |Communicable Disease Control[MESH] |Communicable Diseases/*diagnosis/epidemiology[MESH] |Coronavirus Infections/*diagnosis/epidemiology/prevention & control[MESH] |Diagnostic Tests, Routine[MESH] |Epidemics/prevention & control[MESH] |Humans[MESH] |International Cooperation[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*diagnosis/epidemiology/prevention & control[MESH] |SARS-CoV-2[MESH] |Specimen Handling/standards[MESH]Need for sustainable biobanking networks for COVID-19 and other diseas(epmc).pdf DeepDyve Pubget Overpricing